Evaluation of latest viscoelastic coagulation assays in the transcatheter aortic valve implantation setting.
Jonathon P FanningShaun RobertsMegan MerzaChris AnsteyKarl PoonAlexander IncaniSarvesh NataniJohn FraserPublished in: Open heart (2021)
This study demonstrated a small intraprocedural prothrombotic change of uncertain clinical importance during the transcatheter aortic valve procedure. Further comparison with percutaneous coronary intervention and aortic valve replacement cohorts are needed to assess the merits of current antithrombotic guidelines, which are extrapolated from the PCI setting. The heparin effect was more consistently quantified by ROTEM.
Keyphrases
- aortic valve replacement
- transcatheter aortic valve implantation
- aortic valve
- percutaneous coronary intervention
- aortic stenosis
- transcatheter aortic valve replacement
- coronary artery disease
- acute myocardial infarction
- atrial fibrillation
- acute coronary syndrome
- st segment elevation myocardial infarction
- antiplatelet therapy
- st elevation myocardial infarction
- coronary artery bypass grafting
- venous thromboembolism
- left ventricular
- high throughput
- minimally invasive
- coronary artery bypass
- heart failure
- growth factor
- mass spectrometry